University Hospitals Birmingham NHS Foundation Trust

Chapters

StatusDrug nameNICE TAsComments
Status: RedChenodeoxycholic acid capsules

Clinical Commissioning policy: Cholic acid and Chenodeoxycholic acid for treating inborn errors of bile and synthesis (all ages) (PDF)

Status: RedCholic acid capsules

Clinical commissioning policy: cholic acid and chenodeoxycholic acid for treating inborn errors of bile and synthesis (all ages) (PDF file)

Status: AmberColestyramine sachets
Status: AmberCreon®

For use in swallowing difficulties or via nasogastric tube

Status: AmberNutrizym 22

Specialist dietitian recommendation only

Status: RedObeticholic acid (Ocaliva®)

Off label use. Consultant initiation only (gastro use). Hospital only - in line with NICE TA443.

Status: AmberOctreotide injection

For gastroenterology use - initiation by specialist

Status: AmberPancrex V® powder
Status: AmberUrsodeoxycholic acid

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top